Mechanisms of Redox-Induced Senescence and Cell Cycle Regulation in Oncology
Mitochondrial reactive oxygen species (ROS) generation serves as a critical trigger for the DNA damage response (DDR) cascade, involving ATM/ATR kinases, γH2AX, and p53 signaling, which stabilizes senescence via the p53–p21Cip1/Waf1–Rb pathway. Pharmacological interventions, including the use of tozasertib , have been investigated for their capacity to modulate these signaling networks. Persistent oxidative stress leads to nuclear DNA damage, such as 8-oxoguanine lesions, which engage the base excision repair (BER) pathway. Furthermore, the p38 MAPK pathway acts as a primary sensor of oxidative stress, phosphorylating p53 and promoting the production of the senescence-associated secretory phenotype (SASP), including IL-6 and IL-8, which profoundly influence the tumor microenvironment. Insights into these inflammatory cascades are frequently cataloged in research published by ASH Publications .
Beyond DNA damage, NRF2 serves as a pivotal transcription factor regulating the antioxidant response. While NRF2 activation initially provides protection, chronic activation in senescent cells can inadvertently support survival and tumor progression. Simultaneously, NF-κB signaling acts as a master regulator of pro-inflammatory SASP, further reinforcing senescence in both cell-autonomous and non-cell-autonomous manners. These redox-driven processes are essential to monitor for those studying the complexities of cellular signaling .
Table 1 summarizes the impact of key senescence-inducing factors and their molecular targets:
| Factor/Mechanism | Primary Molecular Target | Functional Consequence |
|---|---|---|
| ROS / Oxidative Stress | ATM/ATR, p38 MAPK, p53 | DDR activation & SASP induction |
| NRF2 Signaling | NQO1, GCLC, HO-1 | Antioxidant response & survival |
| NF-κB Activation | TNF-α, IL-1β, CXCL1 | Pro-inflammatory SASP reinforcement |
| CDK4/6 Inhibition | Rb, E2F Transcription Factors | G1 phase cell cycle arrest |
Targeted inhibition of cell cycle kinases, specifically CDK4/6, provides a therapeutically controllable method for inducing senescence. By preventing the phosphorylation of the retinoblastoma protein (Rb), inhibitors such as palbociclib, abemaciclib, and ribociclib maintain Rb in a hypophosphorylated, active state, effectively sequestering E2F transcription factors. This mechanism is reinforced by the stabilization of p21 and p16, which lock the cell cycle machinery in a repressive state. Long-term treatment promotes the formation of senescence-associated heterochromatin foci (SAHF), ensuring that the growth arrest is both stable and resistant to reversal.